DATA AND HISTORY

P&R S.p.A. is the holding company of an Italian group with a strong international presence of companies operating in the chemical and pharmaceutical sectors.

The company operates mainly in the production of active ingredients (APIs) and works as an intermediary for the pharmaceutical industry, drugs and medical devices created for the treatment of diseases with high socio-economic relevance and as well as in a diverse range of thermoplastic and thermosetting resins.

P&R Group was founded by Dr. Francesco Pizzocaro and Dr. Paolo Rossi, who passed in 2001.
Today the Group is led by Dr. Francesco Pizzocaro.

1984

PROCHIMICA S.r.l. acquisition
Current shareholders entry in PROCHIMICA.

1989

Business expansion and acquisition of Mortara plant (PV)

1995

CD FARMASINT S.r.l. acquisition
Research laboratory for active pharmaceutical ingredients

Dorno plant (PV) Acquisition

1996

SIR INDUSTRIALE S.p.A. acquisition
The company manufactures thermoplastic and thermosetting resins and fine chemicals.

1998

SPREA CHEMICALS S.p.A.  acquisition
The company manufactures thermoplastic and thermosetting resins and fine chemicals.

 

SOLCHEM ITALIANA S.p.A. acquisition
The company manufactures active pharmaceutical ingredients.

1999

FIDIA FARMACEUTICI S.p.A. acquisition
Pharmaceutical company producing mainly viscosupplementation products

LABORATORI MAG S.p.A. acquisition
Company producing of active pharmaceutical ingredients

2001

Merger and acquisition of SPREA CHEMICALS S.p.A. into SIR INDUSTRIALE S.p.A.

2003

ANTIBIOTICOS GROUP acquisition
Manufacturers of active pharmaceutical ingredients by fermentation

Construction of SOLMAG S.p.A.
Born from the merger of Solchem and Laboratori Mag

2010

The name of company changes from ANTIBIOTICOS S.p.A. to OLON S.p.A.

2011 - 2019

Open new branch abroad:

  • 2011 P&R SHANGHAI INTERNATIONAL TRADING
  • 2011 FIDIA PHARMA USA
  • 2012 OLON USA
  • 2013 FIDIA PHARMA GmbH (Germany)
  • 2014 LABORATORIOS FIDIA FARMACEUTICI (Spain)
  • 2015 FIDIA PHARMA RUSSIA
  • 2015 FIDIA PHARMA MIDDLE EAST (Dubai)
  • 2019 FIDIA PHARMA EGYPT

2014

BIOFARMITALIA S.r.l. acquisition
Company specialized in the research and production of transdermal patches, impregnated matrices and dynamic controlled release device.

2016

GLYNN BROTHERS PRAGUE, GLYNN BROTHERS CHEMICALS SLOVAKIA E GLYNN AESTHETIC PRAGUE acquisition
Companies present for years in the Czech and Slovak markets with pharmaceutical products under license from third parties.

INFA GROUP S.p.A. acquisition
Company active in the production of APIs for generic drugs and active in the research and development of molecules for new drugs

2017

SOOFT ITALIA S.p.A. GROUP and OOX ITALIA S.r.l. acquisition
Company actives in pharmaceutical ophthalmic sector.

Acquisition of Chemical Development Division of RICERCA BIOSCIENCE LLC USA.
The company is focused on the research and development of new molecules for pharmaceutical use.

2018

SOLUCIONES BIOREGENERATIVAS S.L. acquisition
A Spanish Biotechnology company engaged in development and production of medical devices for using in medical and surgical regenerative therapies.

2019

OLON ACTIVE PHARMACEUTICAL INGREDIENTS acquisition
Acquisition of the production plant of the company Sandoz Priv. Ltd. and establishment of OLON A.P.I INDIA PVT. LTD in Mahad (India)
Company specialized in the production of active pharmaceutical ingredients.

CAPUA BIOSERVICES S.p.A. acquisition
A company actives in development and production of customized microbial processes.